Sign In
Buy SNN
$31.56
-0.770 (-2.38%)
At Close: Jul 31, 2026
Smith+Nephew Expands ASC Platform to Support Value-Based Care
02:30pm, Thursday, 23'rd Jul 2026
SNN expands ASC Solutions with an integrated platform, analytics and partners to boost efficiency, growth and patient outcomes in outpatient care.
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
12:46pm, Thursday, 16'th Jul 2026
SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions
02:00am, Thursday, 09'th Jul 2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of
New German expert consensus highlights role for NPWT in mitigating the economic impact of postoperative wound complications
02:00am, Thursday, 09'th Jul 2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication by expert clinicians of new consensus-based guidance - developed by them for the use of single
Smith & Nephew: Ongoing Business Progress And A More Attractive Price
07:28am, Thursday, 25'th Jun 2026
Smith & Nephew continues to demonstrate solid business recovery, with robust revenue, profit, and free cash flow growth across all divisions. SNN's 2026 outlook targets 6% underlying revenue growth, 8
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
09:12am, Thursday, 11'th Jun 2026
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
Smith & Nephew's robotics push wins surgeon backing
11:30am, Wednesday, 10'th Jun 2026
Smith & Nephew PLC (LSE:SN) efforts to expand its surgical robotics platform and strengthen its orthopaedics pipeline received a vote of confidence from surgeons at a recent investor event, according
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the next‑generation CORI◊ XT Handheld Robotics Platfo
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the US launch of next generation LEAF ♢ Patient Monitoring System, a data-driven pressure injury prevention platform
VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership
01:25pm, Wednesday, 13'th May 2026
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
09:02am, Wednesday, 06'th May 2026
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript
UK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue rises
02:21am, Wednesday, 06'th May 2026
Medical products maker Smith+Nephew posted a 3.1% rise in first-quarter underlying revenue on Wednesday, helped by strong sports medicine and wound management performance, a
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming Europ
SNN vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th May 2026
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value oppo
SNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year Study
11:40am, Friday, 24'th Apr 2026
Smith+Nephew's CARTIHEAL implant shows superior 5-year outcomes vs. standard care, with a new CPT code set to boost adoption and expand cartilage repair reach.
